Asset Management One Co., Ltd. Novavax Inc Transaction History

Asset Management One Co., Ltd.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 29, 2022	SELL	$36.28 - $75.29 $1.1 Million - $2.27 Million	-30,192 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$69.73 - $142.9 $11,226 - $23,006	-161 Reduced 0.53%	30,192 $2.22 Million
Q4 2021 Feb 09, 2022	SELL	$134.56 - $217.97 $84,772 - $137,321	-630 Reduced 2.03%	30,353 $4.64 Million
Q3 2021 Nov 02, 2021	BUY	$177.8 - $270.58 $50,139 - $76,303	282 Added 0.92%	30,983 $6.42 Million
Q2 2021 Aug 03, 2021	BUY	$121.0 - $257.67 $3.71 Million - $7.91 Million	30,701 New	30,701 $6.52 Million

291

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $674M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Asset Management One Co., Ltd., based on Form 13F filings with the SEC.

Stay updated on Asset Management One Co., Ltd. with notifications on news.